Skip to main content
. 2016 Apr 25;2016(4):CD003455. doi: 10.1002/14651858.CD003455.pub2

Lenz 2010.

Methods RCT. Duration: 2005 to 2008
Follow‐up: 1 year
Participants 30 people with recurrent rectal bleeding, started 6 months after radiotherapy
Mean age 67.4 (SD 11.8); 10% grade 1; 43.3% grade 2; 26.7% grade 3; 20% grade 4.
Comparable groups
Dropouts: APC group: 2 (1 died, 1 refused further therapy after successful reduction of her rectal bleeding (score from 4 to 2 points))
Interventions Intervention: BEC
Comparator: APC
Outcomes Efficacy, complications, relapse
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation was done by sequential opening of numbered, opaque envelopes
Allocation concealment (selection bias) Low risk Randomisation was done by sequential opening of numbered, opaque envelopes
Blinding (performance bias and detection bias) Low risk Unclear whether participants had been blinded, but as both arms received a similar active intervention, it seems unlikely that this would have introduced performance bias
Blinding of outcome assessment subjective Low risk Unclear whether participants had been blinded, but as both arms received a similar active intervention, it seems unlikely that this would have introduced performance bias
Blinding of outcome assessment objective Low risk No information on blinding. However, it is unlikely that objective outcomes were influenced
Incomplete outcome data: subjective outcomes Low risk 2 participants (APC group) did not complete the treatment, despite clinical improvement. The clinical score of 1 of these participants improved from 4 to 3 points, but he died due to pneumonia. The other refused further therapy after successful reduction of her rectal bleeding (score from 4 to 2 points)
Incomplete outcome data: objective outcomes Low risk 2 participants (APC group) did not complete the treatment, despite clinical improvement. The clinical score of 1 of these participants improved from 4 to 3 points, but he died due to pneumonia. The other refused further therapy after successful reduction of her rectal bleeding (score from 4 to 2 points)
Selective reporting (reporting bias) Low risk Protocol was registered on ClinicalTrials.gov (NCT00725244), and all prespecified outcomes have been reported in the article
Other bias Low risk There was no significant difference between the groups regarding pelvic cancer, age, gender, aspirin use, previous medical therapy, or disease severity